Echo Therapeutics, Inc.

Echo Therapeutics, Inc. (Echo Therapeutics) is a medical device and specialty pharmaceuticals company engaged in developing non-invasive (needle-free), wireless, transdermal continuous glucose monitoring (tCGM) system for diabetes and pharmaceutical products. The company uses its AzoneTS skin penetration technology to develop different transdermal reformulations of pharmaceutical products previously approved by the FDA. The company principally operates in the United States. The company is head quartered in Massachusetts, US.

Street: 
10 Forge Parkway
City: 
Franklin
Postcode: 
02038
Federal State : 
United States
WebSite: 
www.echotx.com
Fax: 
1-508-5538760

Company Index Score

Current Index Score Historical Index Score
  • Echo Therapeutics, Inc. currently scores 50 % in the index.
  • Echo Therapeutics, Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Echo Therapeutics, Inc. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets